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Hereditary spastic paraplegias (HSPs) are a group of rare inherited neurodegenerative dis-
orders that result from primary retrograde dysfunction of the long descending ﬁbers of the
corticospinal tract, causing lower limb spasticity and muscular weakness. This group of diseases
has a heterogeneous clinical presentation. An extensive list of associated genes, diﬀerent in-
heritance patterns, and ages at onset have been reported in HSPs.1 Spastic paraplegia type 52
(SPG52) is an autosomal recessive disease caused by AP4S1 mutations. The disease is char-
acterized by neonatal hypotonia that progresses to hypertonia and spasticity in early childhood,
developmental delay, mental retardation, and poor or absent speech. Febrile or afebrile seizures
may also occur.2–4
Clinical case presentation
We report the case of a Portuguese 2-year-old boy born to healthy nonconsanguineous parents
after a full-term gestation with intrauterine growth restriction after week 37. During the ﬁrst
months of life, the patient presented poor weight gain, hyperammonemia with elevation of
glutamine and ornithine, low citrulline, and negative orotic acid. Weight recovery and nor-
malization of amino acid proﬁle were observed after protein restriction and remained normal
after reintroduction of normal diet. Genetic study of urea cycle disorders (NAGS, CPS, and
OTC) was negative. Around 9 months of age, global developmental delay, hypotonia, and
strabismus were evident. Brain MRI with spectroscopy (performed at 10 months) showed
delayed myelination/hypomyelination associated with a posterior perisylvian polymicrogyria,
thinning of the corpus callosum, dilation and dysmorphia of the ventricles, and enlargement of
the subarachnoid frontotemporal space (ﬁgure A). Spectroscopy suggested a possible discrete
reduction of N-acetylaspartate. EEG showed a slight intermittent lentiﬁcation in the left
temporal region. At 15 months of age, the patient had 1 afebrile episode of status epilepticus.
Two previous shorter episodes with fever had also occurred. Levetiracetam was started. No
regression of psychomotor development after seizure was observed, and the patient has been
evolving gradually with improvement of axial hypotonia. He says a few simple words, responds
to his name, and has some nonverbal communication. The most recent neurologic evaluation
revealed an alteration of the muscle tone (hypertonia) in the left lower limb and pyramidal signs
in both legs.
Exome sequencing of the proband and parents was performed as described in Supplementary
Material (links.lww.com/NXG/A86) and revealed the homozygous AP4S1 splice site
NM_001128126.2:c.294+1G>T r.619_687del variant in the proband, present in the hetero-
zygous state in the parents (ﬁgure B). The variant was located in a 2.4-Mb homozygous region
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of chromosome 14. This variant is extremely rare in the
population, with only 1 heterozygous individual present in
the Genome Aggregation Database. In silico analysis predicted
the loss of the donor splice site of exon 4. A transcript size
analysis and Sanger sequencing of cDNA conﬁrmed the
presence of a shorter transcript skipping exon 4 associated
with the variant (ﬁgure C). As a consequence, the polypeptide
of 23 amino acids (76 a.a.–98 a.a.) encoded by exon 4 is lost
(ﬁgure D).
Discussion
AP4S1 encodes the small subunit of the adaptor protein
complex-4 (AP4 complex). This complex is recruited to the
trans-Golgi network, where it mediates vesicle traﬃcking to
endosomes or basolateral plasma membrane in a clathrin-
independent manner.5 Mutations in the 4 subunits of the
complex have been associated with similar autosomal recessive
phenotypes mainly characterized by spastic tetraplegia.6 The
mutation found in our patient leads to the loss of exon 4, with
predicted important consequences to the protein structure and
the AP4 complex function. Anatomical changes similar to
those observed in patients have been reported in an AP-4
complex knockout mouse model: enlargement of the lateral
ventricles and thinning of the corpus callosum.7 Similar
changes have also been seen in the patient described here,
together with febrile and afebrile seizures. When exome se-
quencing was performed and analyzed, the patient did not
show hypertonia in the lower limbs. However, as reported in
other patients, this clinical entity may progress from hypotonic
to hypertonic status. The most recent neurologic evaluation
revealed the presence of hypertonia in the left leg, associated
with pyramidal signs, suggesting the possibility of future de-
velopment of a spastic paraparesis, typical of this disease.
Here, we report a case of SPG52 associated with posterior
perisylvian polymicrogyria, unexplained transitory hyper-
ammonemia, and absence of facial dysmorphisms, which
suggest an expansion of the disease phenotype.
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Figure Patient’s brain imaging, pedigree, and consequences of AP4S1 c.294+1G>T variant
(A) Left image: sagittal T1 weighted image showing thin corpus callosum. Central and right images: axial T2 weighted images showing delayed myelination,
bilateral posterior perisylvian polymicrogyria, dysmorphic and enlarged ventricles, and enlargement of subarachnoid space. (B) Family pedigree. The
proband presents the splice-site variant chr14:g.31542180G>T NM_001128126.2:c.294+1G>T in the homozygous state, and both parents are heterozygous
for the variant. +: c.294+1G>T allele; −: wild-type allele. (C) AP4S1 transcript size of the homozygous patient, both heterozygous parents, and the wild-type
individual. A shorter transcript is produced in the presence of the variant. Each band of the marker ladder represents 100 bp (band size from gel bottom
to top: 100, 200, 300, 400, 500, 600, 700, 800, 900, and 1000 bp). (D) Alignment of the wild-type protein sequence (NP_001121598) to the mutated protein.
The alignment was performed with Clustal Omega. The variant leads to the loss of amino acids 76–98. C− = negative control; F = father; M = marker ladder;
Mo = mother; mut = mutated protein; P = patient; WT = wild-type.
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